Ras activation is associated with Vitamin D receptor mRNA instability in HC11 mammary cells

Journal of Steroid Biochemistry and Molecular Biology

Volumn 92, Issue 1-2, 2004, Pages 89-95

  Rozenchan, Patricia B ^a   Folgueira, Maria A A K ^a   Katayama, Maria L H ^a   Snitcovsky, Igor M L ^a   Brentani, M Mitzi ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Farnesyltransferase inhibitor; Mammary cells; mRNA stability; VDR transcriptional rate; Vitamin D receptor

Indexed keywords

PROTEIN FARNESYLTRANSFERASE INHIBITOR; RAS PROTEIN; RNA; VITAMIN D RECEPTOR;

3' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; BREAST CELL; CONTROLLED STUDY; GENE SEQUENCE; GENETIC TRANSCRIPTION; MOUSE; NONHUMAN; ONCOGENE RAS; PROTEIN DEGRADATION; RNA STABILITY; SIGNAL TRANSDUCTION;

3' UNTRANSLATED REGIONS; ANIMALS; CELLS, CULTURED; DNA MUTATIONAL ANALYSIS; ENZYME ACTIVATION; FEMALE; MAMMARY GLANDS, ANIMAL; MICE; MUTATION; RAS PROTEINS; RECEPTORS, CALCITRIOL; RNA STABILITY; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

MURINAE;

EID: 8444246050     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2004.05.007     Document Type: Article

References (43)

1. J. Welsh, J.A. Wietzke, G.M. Zinser, B. Byrne, K. Smith, and C.J. Narvaez Vitamin D-3 receptor as a target for breast cancer prevention J. Nutr. 133 2003 2425S 2433S
2. R.G. Erben, D.W. Soegiarto, K. Weber, U. Zeitz, M. Lieberherr, R. Gniadecki, G. Moller, J. Adamski, and R. Balling Deletion of deoxyribonucleic acid binding domain of the vitamin D receptor abrogates genomic and nongenomic functions of vitamin D Mol. Endocrinol. 16 2002 1524 1537
3. C.M. Hansen, L. Rohde, M.W. Madsen, D. Hansen, K.W. Colston, G. Pirianov, P.K. Holm, and L. Binderup MCF-7/VD(R): a new vitamin D resistant cell line J. Cell. Biochem. 82 2001 422 436
4. R.R. Buras, L.M. Schumaker, F. Davoodi, R.V. Brenner, M. Shabahang, R.J. Nauta, and S.R. Evans Vitamin D receptors in breast cancer cells Breast Cancer Res. Treat. 31 1994 191 202
5. L. Flanagan, K. Packman, B. Juba, S. O'Neill, M. Tenniswood, and J. Welsh Efficacy of Vitamin D compounds to modulate estrogen receptor negative breast cancer growth and invasion J. Steroid Biochem. Mol. Biol. 84 2003 181 192
6. M. Friedrich, L. Rafi, W. Tilgen, W. Schmidt, and J.V. Reichrath Expression of 1,25-dihydroxyvitamin D3 receptor in breast carcinoma J. Histol. Cytochem. 46 1998 1335 1337
7. 2 vitamin D3 Clin. Endocrinol. (Oxf) 13 1980 267 272
8. 3 receptors in breast cancer and relationship to biochemical and clinical indices Cancer Res. 44 1984 1677 1681
9. M. Friedrich, R. Axt-Fliedner, C. Villena-Heinsen, W. Tilgen, W. Schmidt, and J. Reichrath Analysis of vitamin D-receptor (VDR) and retinoid X-receptor alpha in breast cancer Histochem. J. 34 2002 35 40
10. E.M. Barbosa, S. Nonogaki, M.L.H. Katayama, M.A.A. Folgueira, A.A.F. Venâncio, and M.M. Brentani Vitamin D3 modulation of plasminogen activator inhibitor type-1 in human breast carcinomas under organ culture Virchows Arch. 444 2004 175 182
11. 2 vitamin D3 receptors in T 47D breast cancer cells J. Steroid Biochem. Mol. Biol. 45 1993 257 263
12. 3 and modulation of its receptor Breast Cancer Res. Treat. 54 1999 123 134
13. C.J. Narvaez, G. Zinser, and J. Welsh Functions of 1alpha, 25-dihydroxyvitamin D(3) in mammary gland: from normal development to breast cancer Steroids 66 2001 301 308
14. K.W. Colston, and C.M. Hansen Mechanisms implicated in the growth regulatory effects of vitamin D in breast cancer Endocr. Relat. Cancer 9 2002 45 59
15. M. Sebag, J. Henderson, J. Rhim, and R. Kremer Relative resistance to 1,25-dihydroxyvitamin D3 in a keratinocyte model of tumor progression J. Biol. Chem. 267 1992 12162 12167
16. A. Agadir, G. Lazzaro, Y. Zheng, X.K. Zhang, and R. Mehta Resistance of HBL100 human breast epithelial cells to vitamin D action Carcinogenesis 20 1999 577 582
17. C. Solomon, J.H. White, and R. Kremer Mitogen-activated protein kinase inhibits 1,25-dihydroxyvitamin D3-dependent signal transduction by phosphorylating human retinoid X receptor alpha J. Clin. Invest. 103 1999 1729 1735
18. U. Maurer, F. Jehan, C. Englert, G. Hubinger, E. Weidmann, H.F. DeLuca, and L. Bergmann The Wilms' tumor gene product (WT1) modulates the response to 1,25-dihydroxyvitamin D3 by induction of the vitamin D receptor J. Biol. Chem. 276 2001 3727 3732
19. K.G. Danielson, C.J. Oborn, E.M. Durban, J.S. Butel, and D. Medina Epithelial mouse mammary cell line exhibiting normal morphogenesis in vivo and functional differentiation in vitro Proc. Natl. Acad. Sci. U.S.A. 81 1984 3756 3760
20. N.E. Hynes, D. Taverna, I.M. Harweth, F. Clardiello, D.S. Salomon, T. Yamamoto, and B. Groner Epidermal growth factor receptor, but not c-erb-2, activation prevents lactogenic hormone induction of β-casein gene in mouse mammary epithelial cells Mol. Cell. Biol. 10 1990 4027 4043
21. 3 in HC11 normal mouse mammary cell line J. Steroid Biochem. Mol. Biol. 84 2003 57 69
22. M. Groudine, M. Peretz, and H. Weintraub Transcriptional regulation of hemoglobin switching in chicken embryos Mol. Cell. Biol. 1 1981 281 288
23. C.A. Omer, Z. Chen, R.E. Diehl, M.W. Conner, H.Y. Chen, M.E. Trumbauer, S. Gopal-Truter, G. Seeburger, H. Bhimnathwala, M.T. Abrams, J.P. Davide, M.S. Ellis, J.B. Gibbs, I. Greenberg, K.S. Koblan, A.M. Kral, D. Liu, R.B. Lobell, P.J. Miller, S.D. Mosser, T.J. O'Neill, E. Rands, M.D. Schaber, E.T. Senderak, A. Oliff, and N.E. Kohl Mouse mammary tumor virus-Ki-rasB transgenic mice develop mammary carcinomas that can be growth-inhibited by a farnesyl:protein transferase inhibitor Cancer Res. 60 2000 2680 2688
24. H. Edamatsu, Y. Kaziro, and H. Itoh LUCA15, a putative tumor supressor gene encoding an RNA-binding nuclear protein, is down-regulated in ras-transformed Rat-1 cells Genes Cells 5 2000 849 858
25. G. Klock, S. Storch, J. Rickert, C. Gutacker, and C. Koch-Brandt Differential regulation of the clusterin gene by Ha-ras and c-myc oncogenes and during apoptosis J. Cell. Physiol. 177 1998 593 605
26. T.D. Bui, G. Tortora, F. Ciardiello, and A.L. Harris Expression of Wnt5a is downregulated by extracellular matrix and mutated c-Ha-ras in the human mammary epithelial cell line MCF-10A Biochem. Biophys. Res. Commun. 239 1997 911 917
27. V.R. Martins, and M.M. Brentani The effects of ras gene expression on glucocorticoid receptors in mouse fibroblasts J. Steroid Biochem. Mol. Biol. 37 1990 183 193
28. A.L.B. Cabral, A.N. Hays, P.R. Housley, M.M. Brentani, and V.R. Martins Repression of glucocorticoid receptor gene transcription by c-Jun Mol. Cell. Endocrinol. 175 2001 67 79
29. D.A. Persons, N. Schek, B.L. Hall, and O.J. Finn Increased expression of glycolysis-associated genes in oncogenes-transformed and growth-accelerated states Mol. Carcinog. 2 1989 88 94
30. B. Stefanovic, C. Hellerbrand, M. Holcik, M. Briendl, S.A. Liebhaber, and D.A. Brenner Posttranscriptional regulation of collagen α1(I) mRNA in hepatic stellate cells Mol. Cell. Biol. 17 1997 5201 5209
31. T. Waterboer, M. Rahaus, and M.H. Wolff Varicella-zoster virus (VZV) mediates a delayed host shutoff independent of open reading frame (ORF) 17 expression Virus Genes 24 2002 49 56
32. L.A. Chandler, C.P. Ehretsmann, and S. Bourgeois A novel mechanism of Ha-ras oncogene action: regulation of fibronectin mRNA levels by a nuclear posttranscriptional event Mol. Cell. Biol. 14 1994 3085 3093
33. G. Nebl, N. Mermod, and A.C.B. Cato Post-transcriptional down-regulation of expression of transcription factor NF1 by Ha-ras oncogene J. Biol. Chem. 269 1994 7371 7378
34. A. Cadoret, F. Bertrand, S. Baron-Delage, P. Levy, G. Courtois, C. Gespach, J. Capeau, and G. Cherqui Down-regulation of NF-kappaB activity and NF-kappaB p65 subunit expression by ras and polyoma middle T oncogene in human colonic Caco-2 cells Oncogene 14 1997 1589 1600
35. A.M. Delany, and E. Canalis The metastasis-associated metalloproteinase stromelysin-3 is induced by transforming growth factor-beta in osteoblasts and fibroblasts Endocrinology 142 2001 1561 1566
36. A. Bevilacqua, M.C. Ceriani, S. Capaccioli, and A. Nicolin Post-transcriptional regulation of gene expression by degradation of messenger RNAs J. Cell. Physiol. 195 2003 356 372
37. H. Tourriere, I.E. Gallouzi, K. Chebli, J.P. Capony, J. Mouaikel, P. van der Geer, and J. Tazi RasGAP-associated endoribonuclease G3Bp: selective RNA degradation and phosphorylation-dependent localization Mol. Cell. Biol. 21 2001 7747 7760
38. M.W. Leviten, E.C. Lai, and J.W. Posakony The Drosophila gene Bearded encodes a novel small protein and shares 3' UTR sequence motifs with multiple enhancer of split complex genes Development 124 1997 4039 4051
39. G.P. Prevost, A. Pradines, M.C. Brezak, M.O. Lonchampt, I. Viossat, I. Ader, C. Toulas, P. Kasprzyk, T. Gordon, G. Favre, and B. Morgan Inhibition of human tumor cell growth in vivo by an orally bioavailable inhibitor of human farnesyltransferase, BIM-46228 Int. J. Cancer 91 2001 718 722
40. F.C. von Lintig, A.D. Dreilinger, N.M. Varki, A.M. Wallace, D.E. Casteel, and G.R. Boss Ras activation in human breast cancer Breast Cancer Res. Treat. 62 2000 51 62
41. I.E. Gallouzi, F. Parker, K. Chebli, F. Maurier, E. Labourier, I. Barlat, J.P. Capony, B. Tocque, and J. Tazi A novel phosphorylation-dependent RNase activity of GAP-SH3 binding protein: a potential link between signal transduction and RNA stability Mol. Cell. Biol. 18 1998 3956 3965
42. H. Tourriere, K. Chebli, and J. Tazi mRNA degradation machines in eukaryotic cells Biochimie 84 2002 821 837
43. M.R. Smith, D.L. Newton, S.M. Mikulski, and S.M. Rybak Cell cycle-related differences in susceptibility of NIH/3T3 cells to ribonucleases Exp. Cell Res. 247 1999 220 232